[Standard-of-care systemic therapy with or without SBRT in patients with oligoprogressive breast cancer or NSCLC (CURB oligoprogression): an open-label, randomised, controlled, phase 2 study].

Subjects

Subjects :

Humans
Female
Disease Progression
Middle Aged
Combined Modality Therapy
Aged
Male
Standard of Care
Adult
Breast Neoplasms radiotherapy
Breast Neoplasms therapy
Carcinoma, Non-Small-Cell Lung radiotherapy
Carcinoma, Non-Small-Cell Lung therapy
Radiosurgery
Lung Neoplasms radiotherapy

Details

Language :

German

ISSN :

1439-099X

Volume :

200

Issue :

9

Database :

MEDLINE

Journal :

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Publication Type :

Academic Journal

Accession number :

39120748

Full Text :

https://doi.org/10.1007/s00066-024-02261-3